SciELO - Scientific Electronic Library Online

 
vol.67 issue2Positive assessment of drugs: 1st quarter 2011The Medical Service in the Army's Antarctic Base "Gabriel de Castilla" author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Sanidad Militar

Print version ISSN 1887-8571

Abstract

ARCOS SANCHEZ, C.; SALINAS VELA, F.T.  and  OLMEDILLA GONZALEZ, M.N.. New perspectives in the treatment of Multiple Sclerosis. Sanid. Mil. [online]. 2011, vol.67, n.2, pp.108-114. ISSN 1887-8571.

A best knowledge of etiopathogeny and prognosis of Multiple Sclerosis is allowing the development of new and more effective therapies. Current therapies are divided into three groups: treatments for the acute relapses, disease-modifying therapy and symptomatic treatment. There are six approved drugs available in Spain, also there are two oral new drugs (Cladribina and Fingolimod) and others designed for improving the quality of life of these patients (Frampidina and Sativex) waiting to be approved and some others in different stages of clinical trials that will offer encouraging perspectives in a near future.

Keywords : Multiple sclerosis; Treatment; Drug therapy.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License